Syndax Pharmaceuticals (SNDX) Other Non-Current Assets (2015 - 2026)

Syndax Pharmaceuticals' Other Non-Current Assets history runs 12 years deep, the most recent figure standing at $102000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 53.0% year-over-year to $102000.0; the TTM figure through Mar 2026 stood at $102000.0 (down 53.0% YoY), while the FY2025 annual figure was $102000.0, down 53.0% from the prior year.
• Other Non-Current Assets was $102000.0 for Q1 2026 at Syndax Pharmaceuticals, roughly flat from $102000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $1.0 million in Q1 2022 to a low of $102000.0 in Q4 2025.
• Historically, Other Non-Current Assets has averaged $339625.0 across 5 years, with a median of $217000.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets soared 793.04% in 2022, then plunged 73.06% in 2024.
• A 5-year view of Other Non-Current Assets shows it stood at $115000.0 in 2022, then jumped by 88.7% to $217000.0 in 2023, then changed by 0.0% to $217000.0 in 2024, then plunged by 53.0% to $102000.0 in 2025, then changed by 0.0% to $102000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $102000.0 (Q1 2026), $102000.0 (Q4 2025), and $217000.0 (Q3 2025), per Business Quant data.